Efetividade da vacinação heteróloga com CoronaVac e Pfizer no Brasil.
10 Fev, 2022 | 13:51hVaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil – Nature Medicine
Comentário no Twitter
An analysis of data from Brazil in @NatureMedicine shows that vaccine effectiveness against SARS-CoV-2 infection and severe COVID-19 outcomes declines after two doses of CoronaVac but increases after a booster dose of the Pfizer-BioNTech vaccine. https://t.co/UCgy6cJFIP pic.twitter.com/pXvkxZHXvv
— Nature Portfolio (@NaturePortfolio) February 9, 2022